Laparoscopic radical gastrectomy for gastric cancer: an anatomical approach to right mesogastrium excision and its clinical significance.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
[RESULTS] A total of 376 patients were included, with 166 undergoing laparoscopic radical gastrectomy with D2+CME and 210 receiving traditional laparoscopic D2 gastrectomy.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] D2+CME is a feasible and effective approach for laparoscopic radical gastrectomy for gastric cancer. The mesogastric anatomical-guided method for suprapyloric lymph node dissection is safe, reliable, and improves lymph node dissection quality while reducing operative time.
[OBJECTIVE] Radical gastrectomy for gastric cancer involves the en-bloc resection of the primary tumor and complete excision of the mesogastrium.
APA
Pan G, Guo Z, et al. (2025). Laparoscopic radical gastrectomy for gastric cancer: an anatomical approach to right mesogastrium excision and its clinical significance.. Frontiers in oncology, 15, 1573018. https://doi.org/10.3389/fonc.2025.1573018
MLA
Pan G, et al.. "Laparoscopic radical gastrectomy for gastric cancer: an anatomical approach to right mesogastrium excision and its clinical significance.." Frontiers in oncology, vol. 15, 2025, pp. 1573018.
PMID
40308489 ↗
Abstract 한글 요약
[OBJECTIVE] Radical gastrectomy for gastric cancer involves the en-bloc resection of the primary tumor and complete excision of the mesogastrium. However, the surgical boundaries and techniques for removing lymph nodes above the pylorus during gastric cancer surgery remain unclear. We aimed to investigate a novel, standardized approach for excising the right mesogastrium in gastric cancer patients undergoing suprapyloric lymphadenectomy, focusing on surgical techniques and outcomes.
[METHODS] Our surgical technique includes identifying three key elements of the mesogastrium: the encircling portion, the suspension point, and the connecting segment. Using these anatomical landmarks, we resect adipose tissue containing lymph nodes from the right mesogastrium and perform root ligation of the right gastric vessels. We then perform D2 lymphadenectomy combined with complete mesogastrium excision (D2+CME). We retrospectively analyzed clinical data from 376 patients who underwent laparoscopic radical gastrectomy with lymph node dissection for gastric cancer, comparing outcomes between laparoscopic suprapyloric lymph node dissection guided by mesogastric anatomy and traditional methods.
[RESULTS] A total of 376 patients were included, with 166 undergoing laparoscopic radical gastrectomy with D2+CME and 210 receiving traditional laparoscopic D2 gastrectomy. No significant differences were observed between the groups in age, body mass index, comorbidities, ASA score, tumor differentiation, tumor location, or surgical approach (>0.05). The D2+CME group harvested significantly more lymph nodes than the traditional D2 group (43.84 ± 5.01 vs. 33.18 ± 2.96, <0.001). The number of positive lymph nodes was also higher in the D2+CME group (6.12 ± 0.89 vs. 2.86 ± 0.55, <0.001). The number of lymph nodes harvested from the right mesogastrium was greater in the D2+CME group (3.41 ± 0.48 vs. 1.32 ± 0.37, <0.001). Intraoperative blood loss was lower in the D2+CME group (5.67 ± 0.41 vs. 9.96 ± 0.77, <0.001), and dissection time was shorter (27.22 ± 1.50 vs. 31.31 ± 1.53, <0.001). No significant difference was found in the number of positive lymph nodes in the right mesogastrium (>0.05).
[CONCLUSION] D2+CME is a feasible and effective approach for laparoscopic radical gastrectomy for gastric cancer. The mesogastric anatomical-guided method for suprapyloric lymph node dissection is safe, reliable, and improves lymph node dissection quality while reducing operative time.
[METHODS] Our surgical technique includes identifying three key elements of the mesogastrium: the encircling portion, the suspension point, and the connecting segment. Using these anatomical landmarks, we resect adipose tissue containing lymph nodes from the right mesogastrium and perform root ligation of the right gastric vessels. We then perform D2 lymphadenectomy combined with complete mesogastrium excision (D2+CME). We retrospectively analyzed clinical data from 376 patients who underwent laparoscopic radical gastrectomy with lymph node dissection for gastric cancer, comparing outcomes between laparoscopic suprapyloric lymph node dissection guided by mesogastric anatomy and traditional methods.
[RESULTS] A total of 376 patients were included, with 166 undergoing laparoscopic radical gastrectomy with D2+CME and 210 receiving traditional laparoscopic D2 gastrectomy. No significant differences were observed between the groups in age, body mass index, comorbidities, ASA score, tumor differentiation, tumor location, or surgical approach (>0.05). The D2+CME group harvested significantly more lymph nodes than the traditional D2 group (43.84 ± 5.01 vs. 33.18 ± 2.96, <0.001). The number of positive lymph nodes was also higher in the D2+CME group (6.12 ± 0.89 vs. 2.86 ± 0.55, <0.001). The number of lymph nodes harvested from the right mesogastrium was greater in the D2+CME group (3.41 ± 0.48 vs. 1.32 ± 0.37, <0.001). Intraoperative blood loss was lower in the D2+CME group (5.67 ± 0.41 vs. 9.96 ± 0.77, <0.001), and dissection time was shorter (27.22 ± 1.50 vs. 31.31 ± 1.53, <0.001). No significant difference was found in the number of positive lymph nodes in the right mesogastrium (>0.05).
[CONCLUSION] D2+CME is a feasible and effective approach for laparoscopic radical gastrectomy for gastric cancer. The mesogastric anatomical-guided method for suprapyloric lymph node dissection is safe, reliable, and improves lymph node dissection quality while reducing operative time.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Resection for stage IV non-small cell lung cancer: Beyond the extent of resection.
- Enhancing platinum-based chemotherapy efficacy and safety through combination therapy-mediated remodeling of autophagic homeostasis in gastric cancer.
- MTSS1-dependent ubiquitin modifications mediated by FBXO44 remodel the actin cytoskeleton to promote gastric cancer progression.
- Colorectal cancer cell-derived exosomes induce metabolic reprogramming of cancer-associated fibroblasts to promote colorectal cancer growth.
- Novel Stemness-Associated Scores: Enhancing Predictions of Hepatocellular Carcinoma Prognosis and Tumor Immune Microenvironment.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Association of preoperative frailty and prognostic nutritional index with postoperative delirium in elderly gastric cancer patients: A single-center observational study.
- Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.
- Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K/Akt signaling pathway-mediated ferroptosis.
- Correction: Survival disparities and predictors in gastric cancer: a population-based study from Kazakhstan (2012-2023).